Table 2.
Univariate | Multivariate | |||||
---|---|---|---|---|---|---|
HR | 95% CI | p - value | HR | 95% CI | p - value | |
Age > 65 | 1.482 | 1.266–1.734 | < 0.001 | 1.476 | 1.245–1.750 | < 0.001 |
Sex (male) | 1.178 | 1.008–1.377 | 0.039 | 1.097 | 0.926–1.299 | 0.284 |
ECOG PS ≥ 2 | 1.648 | 1.385–1.961 | < 0.001 | 1.495 | 1.240–1.802 | < 0.001 |
Hb < 10.0 g/dL | 1.271 | 1.086–1.488 | 0.003 | 1.030 | 0.852–1.244 | 0.763 |
Calcium ≥10.2 mg/dL | 1.372 | 1.117–1.686 | 0.003 | 1.124 | 0.896–1.409 | 0.312 |
Diagnosis at 2009–2014a | 0.638 | 0.386–1.054 | 0.079 | |||
Diagnosis at 2015–2017a | 0.641 | 0.388–1.062 | 0.084 | |||
Log2 EASIX > 1.87 | 1.878 | 1.600–2.205 | < 0.001 | 1.444 | 1.170–1.780 | 0.001 |
ISS 2b | 1.361 | 1.527–2.300 | < 0.001 | 1.226 | 0.966–1.557 | 0.094 |
ISS 3b | 1.874 | 1.101–1.682 | < 0.001 | 1.309 | 1.000–1.714 | 0.050 |
High-risk CA | 1.838 | 1.469–2.300 | < 0.001 | 1.565 | 1.241–1.973 | < 0.001 |
Abbreviations: ECOG PS Eastern Cooperative Oncology Group Performance Status, Hb Hemoglobin, EASIX Endothelial Activation and Stress Index, ISS International Staging System, R-ISS Revised-International Staging, System, CA Chromosomal abnormality
a Diagnosis at 2003–2008 is the reference
bISS 1 is the reference